Heath
H
III, Hodgson
SF, Kennedy
MA. Primary hyperparathyroidism: incidence, morbidity, and potential impact in a community. N Engl J Med. 1980;302189- 193
Mundy
GR, Cove
DH, Fisken
R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet. 1980;11317- 1320
Wermers
RA, Khosla
S, Atkinson
EJ, Hodgson
SF, O'Fallon
WM, Melton
LJ
III. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med. 1997;126433- 440
Consensus Development Conference Panel, National Institutes of Health,
Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med. 1991;114593- 597
Posen
S, Clifton-Bligh
P, Reeve
TS, Wagstaffe
C, Wilkinson
M. Is parathyroidectomy of benefit in primary hyperparathyroidism? QJM. 1985;54241- 251
Davies
M. Primary hyperparathyroidism: aggressive or conservative treatment? Clin Endocrinol (Oxf). 1992;36325- 332
Ljunghall
S, Hellman
P, Rastad
J, Åkerström
G. Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture. World J Surg. 1991;15681- 687
Clark
OH. Asymptomatic primary hyperparathyroidism: is parathyroidectomy indicated? Surgery. 1994;116947- 953
Sosa
JA, Powe
NR, Levine
MA, Udelsman
R, Zeiger
MA. Thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons. J Clin Endocrinol Metab. 1998;832658- 2665
Joborn
C, Hetta
J, Lind
L, Rastad
J, Åkerström
G, Ljunghall
S. Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. Surgery. 1989;10572- 78
Clark
OH, Wiles
W, Siperstein
AE, Duh
QY. Diagnosis and management of primary hyperparathyroidism: safety, efficacy and deficiencies in our knowledge. J Bone Miner Res. 1991;6(suppl 2)S135- S142
Rubinoff
H, McCarthy
H, Hiatt
RA. Hypercalcemia: long-term follow-up with matched controls. J Chronic Dis. 1983;36859- 868
Posen
S. Asymptomatic primary hyperparathyroidism: a case for conservative management. Aust N Z J Med. 1992;22161- 163
Fisher
JA. "Asymptomatic" and symptomatic primary hyperparathyroidism. Clin Investigator. 1993;71505- 518
Okamoto
T, Gerstein
HC, Obara
T. Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism: a systematic overview of the literature. Endocr J. 1997;44367- 374
Goldberg
DP, Williams
P. A User's Guide to the General Health Questionnaire: GHQ. Windsor, England National Foundation for Education Research, Nelson Publishing1988;
Nakagawa
Y, Daibo
I. The Japanese Version of the General Health Questionnaire [in Japanese]. Tokyo, Japan Nippon Bunka Kagakusha1985;
Ormel
J, Koeter
MWJ, van den Brink
W, Giel
R. Concurrent validity of GHQ-28 and PSE as measures of change. Psychol Med. 1989;191007- 1013
Jensen
MP, Turner
JA, Romano
JM. What is the maximum number of levels needed in pain intensity measurement? Pain. 1994;58387- 392
Ormel
J, Koeter
MWJ, van den Brink
W. Measuring change with the General Health Questionnaire (GHQ): the problem of retest effects. Soc Psychiatry Psychiatr Epidemiol. 1989;24227- 232
Not Available,
SPSS 10.0 Application Guides. Chicago, Ill SPSS Inc1999;
Rastad
J, Joborn
C, Åkerström
G, Ljunghall
S. Incidence, type and severity of psychic symptoms in patients with sporadic primary hyperparathyroidism. J Endocrinol Invest. 1992;15(suppl 6)149- 156
Joborn
C, Hetta
J, Rastad
J, Ågren
H, Åkerström
G, Ljunghall
S. Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism. Biol Psychiatry. 1988;23149- 158
Goldstein
DA, Chui
LA, Massry
SG. Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity. J Clin Invest. 1978;6288- 93
Chan
AK, Duh
QY, Katz
MH, Siperstein
AE, Clark
OH. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy: a case-control study. Ann Surg. 1995;222402- 414
Siperstein
AE, Shen
W, Chan
AK, Duh
QY, Clark
OH. Normocalcemic hyperparathyroidism: biochemical and symptom profiles before and after surgery. Arch Surg. 1992;1271157- 1163
Brown
GG, Preisman
RC, Kleerekoper
M. Neurobehavioral symptoms in mild primary hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy. Henry Ford Hosp Med J. 1987;35211- 215
Pasieka
JL, Parsons
LL. Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg. 1998;22513- 519
Talpos
GB, Bone
HG
III, Kleerekoper
M.
et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery. 2000;1281013- 1021
Solomon
BL, Schaaf
M, Smallridge
RC. Psychologic symptoms before and after parathyroid surgery. Am J Med. 1994;96101- 106
Streiner
DL, Norman
GF. PDQ Epidemiology. 2nd ed. St Louis, Mo Mosby1996;
Lundgren
E, Ljunghall
S, Åkerström
G, Hetta
J, Mallmin
H, Rastad
J. Case-control study on symptoms and signs of "asymptomatic" primary hyperparathyroidism. Surgery. 1998;124980- 986
Fish
RG, Crymes
TP, Lovell
M. Internal-mammary-artery ligation for angina pectoris: its failure to produce relief. N Engl J Med. 1958;259418- 420
Cobb
LA, Thomas
GI, Dillard
DH, Merendino
KA, Bruce
RA. An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med. 1959;2601115- 1118